Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.80 |
| ▸ | CA9 | Q16790 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.35 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.35 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.34 |
| ▸ | GLS | O94925 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL273031 | 1.00 | CA1 (0.80) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL114946 | 1.00 | CA1 (0.80) | CA1CA9ALDH1A1LMNATP53 | |
| Tetrahydrofuran SCHEMBL20339203 | 1.00 | CA1 (0.80) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL30489732 | 1.00 | CA1 (0.80) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL7857216 | 1.00 | CA1 (0.80) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL24983738 | 1.00 | CA1 (0.80) | CA1CA9ALDH1A1LMNATP53 | |
| Tetrahydrofuran SCHEMBL7762875 | 0.98 | CA1 (0.76) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL8651090 | 0.98 | CA1 (0.76) | CA1CA9ALDH1A1LMNATP53 | |
| Tetrahydrofuran SCHEMBL28748839 | 0.97 | CA1 (0.84) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL8467388 | 0.95 | CA1 (0.71) | CA1CA9ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| WO-2024156688-A1 | BIODEGRADABLE PERFUME COMPOSITION | GIVAUDAN SA (CH) | 2024-08-02 | — | — | WO | claimed |
| EP-4407019-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2024-07-31 | — | — | EP | claimed |
| US-20240197243-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | GIVAUDAN SA (CH) | 2024-06-20 | — | — | US | claimed |
| EP-4347757-A1 | FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING | Givaudan SA (CH) | 2024-04-10 | — | — | EP | claimed |
| US-11820961-B2 | Musk compositions and methods of use thereof | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-11-21 | — | — | US | claimed |
| WO-2004098666-A1 | CONTROL OF FEMALE BODY ODOURS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2004-11-18 | — | — | WO | claimed |
| WO-2004098667-A1 | CONTROL OF BODY ODOURS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2004-11-18 | — | — | WO | claimed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| CN-1394139-A | Anticancer agents | SODA AROMATIC (JP) | 2003-01-29 | — | — | CN | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| WO-1994002114-A9 | METHOD FOR PREVENTING UNPLEASANT SMELLS DURING HAIR PERMING, AND COMPOSITION THEREFOR | OREAL (FR) | 2002-07-04 | — | — | WO | claimed |
| WO-1998056337-A1 | MALODOR REDUCING COMPOSITION CONTAINING AMBER AND MUSK MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-17 | — | — | WO | claimed |
| US-5501805-A | CONTAINING MUSK, SALICYLATE, ADDITIONAL FRAGRANCES; HAVING LOW ODOR INTENSITY | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1996-03-26 | — | — | US | claimed |
| US-5120709-A | Applying a solution of one or more fixative agents separately | NEUROSCENTS, INC. (US) | 1992-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | CA1 1636/4885CA9 1111/4885ALDH1A1 397/4885 |
| US-11820961-B2 | Musk compositions and methods of use thereof | MUSK, MSI2, SYMPK | CA1 2689/4885CA9 2030/4885ALDH1A1 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.